S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
Free Trial

argenx (ARGX) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free ARGX Stock Alerts
$370.68
-5.58 (-1.48%)
(As of 04:00 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
marketbeat.com logoargenx (NASDAQ:ARGX) Shares Gap Down to $376.26
marketbeat.com - April 16 at 11:56 AM
globenewswire.com logoargenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease
globenewswire.com - April 16 at 1:00 AM
MarketBeat logoargenx SE (NASDAQ:ARGX) Short Interest Down 10.4% in March
americanbankingnews.com - April 15 at 6:42 AM
marketbeat.com logoAllspring Global Investments Holdings LLC Purchases 15,431 Shares of argenx SE (NASDAQ:ARGX)
marketbeat.com - April 13 at 6:30 AM
markets.businessinsider.com logoCartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy
markets.businessinsider.com - April 10 at 3:27 PM
marketbeat.com logoargenx SE (NASDAQ:ARGX) Position Boosted by Raymond James Financial Services Advisors Inc.
marketbeat.com - April 5 at 4:17 AM
marketbeat.com logoChina Universal Asset Management Co. Ltd. Has $1.42 Million Holdings in argenx SE (NASDAQ:ARGX)
marketbeat.com - April 4 at 6:54 PM
nasdaq.com logoGuru Fundamental Report for ARGX
nasdaq.com - March 30 at 4:19 PM
markets.businessinsider.com logoBuy Rating Affirmed for Argenx Se on Efgartigimod Progress and Regulatory Success
markets.businessinsider.com - March 29 at 9:45 AM
msn.com logoHere's Why argenx SE (ARGX) Pulled Back 23% in Q4
msn.com - March 29 at 9:45 AM
finance.yahoo.com logoHere’s Why argenx SE (ARGX) Pulled Back 23% in Q4
finance.yahoo.com - March 29 at 9:45 AM
marketbeat.com logoargenx SE (NASDAQ:ARGX) to Post Q3 2024 Earnings of ($1.01) Per Share, Wedbush Forecasts
marketbeat.com - March 28 at 8:44 AM
markets.businessinsider.com logoBuy Rating Affirmed for Argenx Se on Strong Pipeline and Market Potential
markets.businessinsider.com - March 27 at 3:40 PM
marketbeat.com logoargenx's (ARGX) Buy Rating Reaffirmed at HC Wainwright
marketbeat.com - March 27 at 10:59 AM
markets.businessinsider.com logoReaffirming Buy Rating for Argenx with New Price Objective Following Vyvgart’s Approval in Japan
markets.businessinsider.com - March 27 at 10:39 AM
markets.businessinsider.com logoKey Takeaways From argenx Analyst Ratings
markets.businessinsider.com - March 27 at 10:39 AM
finance.yahoo.com logoargenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease
finance.yahoo.com - March 27 at 10:39 AM
marketbeat.com logoWedbush Equities Analysts Increase Earnings Estimates for argenx SE (NASDAQ:ARGX)
marketbeat.com - March 27 at 6:34 AM
globenewswire.com logoargenx Advances Clinical Development of Efgartigimod in Primary Sjogren's Disease
globenewswire.com - March 27 at 2:00 AM
globenewswire.com logoargenx Announces Annual General Meeting of Shareholders on May 7, 2024
globenewswire.com - March 26 at 4:00 PM
marketbeat.com logoAssenagon Asset Management S.A. Has $48.88 Million Stock Position in argenx SE (NASDAQ:ARGX)
marketbeat.com - March 26 at 1:56 PM
marketbeat.com logoScotiabank Raises argenx (NASDAQ:ARGX) Price Target to $408.00
marketbeat.com - March 26 at 8:26 AM
finanznachrichten.de logoargenx SE: argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
finanznachrichten.de - March 26 at 5:42 AM
globenewswire.com logoargenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thrombocytopenia
globenewswire.com - March 26 at 2:00 AM
markets.businessinsider.com logoBuy Rating Affirmed for Argenx Following Competitive Drug Trial Failure and Promising Market Prospects for Vyvgart
markets.businessinsider.com - March 25 at 3:36 AM
marketbeat.com logoargenx (NASDAQ:ARGX) Stock Rating Reaffirmed by JMP Securities
marketbeat.com - March 22 at 2:10 PM
markets.businessinsider.com logoBuy Rating for Argenx Se Amid VYVGART’s Market Dominance and Revenue Growth Forecast
markets.businessinsider.com - March 21 at 11:24 PM
marketbeat.com logoargenx (NASDAQ:ARGX) Shares Gap Up to $356.95
marketbeat.com - March 21 at 3:14 PM
msn.com logoArgenx gains after setback to Roche/Chugai myasthenia gravis therapy
msn.com - March 21 at 7:36 AM
finance.yahoo.com logoReasons to Invest in argenx (ARGX)
finance.yahoo.com - March 19 at 12:04 PM
investing.com logoargenx NV ADR (ARGX)
investing.com - March 19 at 7:04 AM
marketbeat.com logoWellington Management Group LLP Reduces Stock Position in argenx SE (NASDAQ:ARGX)
marketbeat.com - March 18 at 4:53 AM
markets.businessinsider.com logoAnalysts’ Top Healthcare Picks: Argenx Se (ARGX), MoonLake Immunotherapeutics (MLTX)
markets.businessinsider.com - March 15 at 7:43 AM
marketbeat.com logoAmerican Century Companies Inc. Reduces Holdings in argenx SE (NASDAQ:ARGX)
marketbeat.com - March 15 at 6:20 AM
marketbeat.com logoargenx (NASDAQ:ARGX) Stock Price Down 3.6%
marketbeat.com - March 13 at 2:58 PM
marketbeat.com logoargenx SE (NASDAQ:ARGX) Holdings Raised by Hudson Bay Capital Management LP
marketbeat.com - March 13 at 10:42 AM
marketbeat.com logoNorthern Trust Corp Acquires 11,627 Shares of argenx SE (NASDAQ:ARGX)
marketbeat.com - March 11 at 4:58 AM
marketbeat.com logoTimesSquare Capital Management LLC Buys 11,060 Shares of argenx SE (NASDAQ:ARGX)
marketbeat.com - March 10 at 11:47 AM
finanznachrichten.de logoargenx SE: argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting
finanznachrichten.de - March 8 at 10:27 AM
marketbeat.com logo47,735 Shares in argenx SE (NASDAQ:ARGX) Acquired by Royal London Asset Management Ltd.
marketbeat.com - March 8 at 8:18 AM
globenewswire.com logoargenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting
globenewswire.com - March 7 at 4:01 PM
finance.yahoo.com logoShould You be Confident in Your Investment in argenx SE (ARGX)?
finance.yahoo.com - March 7 at 8:58 AM
marketbeat.com logoRTW Investments LP Acquires 25,000 Shares of argenx SE (NASDAQ:ARGX)
marketbeat.com - March 6 at 11:00 AM
marketbeat.com logoargenx SE (NASDAQ:ARGX) Holdings Cut by Rock Springs Capital Management LP
marketbeat.com - March 5 at 7:21 PM
marketbeat.com logoSchonfeld Strategic Advisors LLC Grows Position in argenx SE (NASDAQ:ARGX)
marketbeat.com - March 3 at 8:28 AM
seekingalpha.com logoargenx SE (ARGX) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 3 at 12:21 AM
realmoney.thestreet.com logoArgenx price target raised by $56 at Scotiabank, here's why
realmoney.thestreet.com - March 1 at 3:00 PM
finance.yahoo.com logoargenx SE (NASDAQ:ARGX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 1 at 3:00 PM
marketbeat.com logoargenx (NASDAQ:ARGX) Issues Earnings Results
marketbeat.com - March 1 at 1:57 PM
marketbeat.com logoargenx (NASDAQ:ARGX) Price Target Increased to $402.00 by Analysts at Scotiabank
marketbeat.com - March 1 at 12:50 PM
Get argenx News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARGX and its competitors with MarketBeat's FREE daily newsletter.

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

ARGX Media Mentions By Week

ARGX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARGX
News Sentiment
▼
1.47

0.66
▲
Average
Medical
News Sentiment

ARGX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARGX Articles
This Week
▼
6

6
▲
ARGX Articles
Average Week

Get argenx News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARGX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ARGX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Can't believe it's happening again
Manward Press
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing